Author

Thomas Klein

Boehringer Ingelheim (Germany)ORCID 0000-0001-5762-9166Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Thomas Klein2 papers · Boehringer Ingelheim (Germany)

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Carla HorváthiD· 1 shared Christian WolfrumiD· 1 shared Fen Long· 1 shared Heike NeubaueriD· 1 shared Manuel Klug· 1 shared Tenagne D. ChallaiD· 1 shared Vissarion EfthymiouiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Carla HorváthORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PhysiologyDiabetes Obesity and MetabolismPeer-reviewedDec 12, 2025

Hepatic GCGR is required for the superior weight loss effects of a structurally related analogue of the dual GCGR/GLP1R agonist survodutide

Fen Long, Tenagne D. Challa, Vissarion Efthymiou…·Carla Horváth

The paper shows that hepatic GCGR is essential for the enhanced weight loss and lipid clearance effects of a dual GCGR/GLP1R agonist compared to a selective GLP1R agonist.

3 citations

humanexperimental assay